Drug

Olverembatinib clinical trials

Also written HQP1351.

studies test it: 27
open now: 18
in phase 3: 4
first study started: 2018

Keep track of what changes. Save the olverembatinib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

26 studies that test it; most in 2022 (6); 1 more planned to start later

Studies that test olverembatinib, by start year
Year	Studies
2018	1
2019	5
2022	6
2023	3
2024	6
2025	4
2026	1

By phase

A phase 1/2 study counts in both.

Early Phase 1: 1
Phase 1: 8
Phase 2: 15
Phase 3: 4
No phase: 1

What it is tested for

Each study’s main condition, where its own words name it.

Precursor Cell Lymphoblastic Leukemia-Lymphoma: 9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: 5
Gastrointestinal Stromal Tumors: 1
Blast Crisis: 1
Neoplasms: 1

Who runs them

Industry 9 · Other 18

Ascentage Pharma Group Inc. (9) · Institute of Hematology & Blood Diseases Hospital, China (6) · M.D. Anderson Cancer Center (3) · The First Affiliated Hospital of Soochow University (3) · First Affiliated Hospital of Zhejiang University (1) · Nanfang Hospital, Southern Medical University (1) · Xijing Hospital (1) · Chen Suning (1)

Often tested with

Tested in the same studies.

Venetoclax (6) · Blinatumomab (3) · Dexamethasone (2) · Inotuzumab Ozogamicin (1) · Decitabine (1) · Lisaftoclax (1) · Allogeneic Anti-CD19 T-cells ThisCART19A (1) · Chimeric Antigen Receptor T-cells (1)

Studies

Open first, then newest update. How each study uses olverembatinib is read from its arms, and is right about nine times in ten.

Testing it · 27

See all 27 studies that test olverembatinib →

Given in every arm · 4 — olverembatinib is usual care beside what is tested

Codes

What other systems call olverembatinib · ClinicalTrials.gg INT006263

MeSH (NLM) C579813olverembatinibConfirmed ClinicalTrials.gov, NLM
UNII (FDA) KV1M7Q3CBPOLVEREMBATINIBConfirmed FDA, NLM, Wikidata
Wikidata Q123846205olverembatinibConfirmed FDA, NLM, Wikidata
NCI Thesaurus C165549OlverembatinibOne source FDA
DrugBank DB16185One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	C579813	olverembatinib	Confirmed ClinicalTrials.gov, NLM
UNII (FDA)	KV1M7Q3CBP	OLVEREMBATINIB	Confirmed FDA, NLM, Wikidata
Wikidata	Q123846205	olverembatinib	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C165549	Olverembatinib	One source FDA
DrugBank	DB16185	—	One source Wikidata

Also registered as olverembatinib dimesylate (UNII NPJ9AW8AZR).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.